跳至主要内容
临床试验/NCT02527005
NCT02527005已完成1 期

A Comparative Study of Azithromycin and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant HIV Positive Patients

University of Ibadan1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2015年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
140
试验地点
1
主要终点
Level of malaria parasitemia at delivery in HIV positive women following administration of Azithromycin or Sulphadoxine- pyrimethamine as intermittent preventive therapy for malaria in pregnancy

研究概览

简要总结

Randomized controlled single blind prospective comparative study

详细描述

This study is intended to be a randomized controlled single blind prospective comparative study conducted to compare the efficacy of three monthly doses of sulphadoxine-pyrimethamine as intermittent preventive therapy for malaria with azithromycin in HIV positive pregnant women

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant HIV positive patients,
  • Gestational age 16 weeks and above,
  • No history of azithromycin or sulphadoxine-pyrimethamine use four weeks prior to recruitment

排除标准

  • Anaemia packed cell volume less than 30%,
  • pre-existing medical conditions- diabetes mellitus,
  • hypertension,
  • allergy to sulphadoxine-pyrimethamine or azithromycin

研究组 & 干预措施

Azithromycin

Active Comparator

Tabs Azithromycin 500mg daily for 3 days

干预措施: Sulphadoxine-pyrimethamine (Drug)

Azithromycin

Active Comparator

Tabs Azithromycin 500mg daily for 3 days

干预措施: Azithromycin (Drug)

Sulphadoxine-pyrimethamine

Active Comparator

500mg of sulphadoxine and 25mg of pyrimethamine 3 tablets every 4 weeks for 3 doses

干预措施: Sulphadoxine-pyrimethamine (Drug)

Sulphadoxine-pyrimethamine

Active Comparator

500mg of sulphadoxine and 25mg of pyrimethamine 3 tablets every 4 weeks for 3 doses

干预措施: Azithromycin (Drug)

结局指标

主要结局

Level of malaria parasitemia at delivery in HIV positive women following administration of Azithromycin or Sulphadoxine- pyrimethamine as intermittent preventive therapy for malaria in pregnancy

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ORIYOMI OMOTOYOSI AKINYOTU

Senior Registrar

University of Ibadan

研究点 (1)

Loading locations...

相似试验